| Immune response to SARS-CoV-2 variants of concern in vaccinated individuals M Becker, A Dulovic, D Junker, N Ruetalo, PD Kaiser, YT Pinilla, ... Nature communications 12 (1), 3109, 2021 | 144 | 2021 |
| Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled … PG Kremsner, RAA Guerrero, E Arana-Arri, GJA Martinez, M Bonten, ... The Lancet Infectious Diseases 22 (3), 329-340, 2022 | 138 | 2022 |
| Comprehensive study of proteasome inhibitors against Plasmodium falciparum laboratory strains and field isolates from Gabon A Kreidenweiss, PG Kremsner, B Mordmüller Malaria journal 7, 1-8, 2008 | 131 | 2008 |
| Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2: A phase 1 randomized clinical trial PG Kremsner, P Mann, A Kroidl, I Leroux-Roels, C Schindler, JJ Gabor, ... Wiener Klinische Wochenschrift 133 (17), 931-941, 2021 | 102 | 2021 |
| Phase 1 assessment of the safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2 in human volunteers P Kremsner, P Mann, J Bosch, R Fendel, JJ Gabor, A Kreidenweiss, ... MedRxiv, 2020.11. 09.20228551, 2020 | 94 | 2020 |
| In vitro activity of ferroquine (SAR97193) is independent of chloroquine resistance in Plasmodium falciparum A Kreidenweiss, PG Kremsner, K Dietz, B Mordmuller American Journal of Tropical Medicine and Hygiene 75 (6), 1178-1181, 2006 | 65 | 2006 |
| Hemolysis is associated with low reticulocyte production index and predicts blood transfusion in severe malarial anemia R Fendel, C Brandts, A Rudat, A Kreidenweiss, C Steur, I Appelmann, ... PloS one 5 (4), e10038, 2010 | 64 | 2010 |
| Clinical utility of tafenoquine in the prevention of relapse of Plasmodium vivax malaria: a review on the mode of action and emerging trial data AB Hounkpatin, A Kreidenweiss, J Held Infection and drug resistance, 553-570, 2019 | 61 | 2019 |
| 2A and the Auxin-Based Degron System Facilitate Control of Protein Levels in Plasmodium falciparum A Kreidenweiss, AV Hopkins, B Mordmüller PLoS One 8 (11), e78661, 2013 | 56 | 2013 |
| Antimalarial compounds in Phase II clinical development J Held, S Jeyaraj, A Kreidenweiss Expert opinion on investigational drugs 24 (3), 363-382, 2015 | 55 | 2015 |
| Heterologous protection against malaria by a simple chemoattenuated PfSPZ vaccine regimen in a randomized trial Z Sulyok, R Fendel, B Eder, FR Lorenz, N Kc, M Karnahl, A Lalremruata, ... Nature communications 12 (1), 2518, 2021 | 48 | 2021 |
| Plasmodia express two threonine-peptidase complexes during asexual development B Mordmüller, R Fendel, A Kreidenweiss, C Gille, R Hurwitz, WG Metzger, ... Molecular and biochemical parasitology 148 (1), 79-85, 2006 | 43 | 2006 |
| Antimalarial Activity of a Synthetic Endoperoxide (RBx-11160/OZ277) against Plasmodium falciparum Isolates from Gabon A Kreidenweiss, B Mordmüller, S Krishna, PG Kremsner Antimicrobial agents and chemotherapy 50 (4), 1535-1537, 2006 | 39 | 2006 |
| Longitudinal monitoring of lactate in hospitalized and ambulatory COVID-19 patients TP Velavan, A Kreidenweiss, J Gabor, S Krishna, PG Kremsner The American Journal of Tropical Medicine and Hygiene 104 (3), 1041, 2021 | 38 | 2021 |
| Lactate as a novel quantitative measure of viability in Schistosoma mansoni drug sensitivity assays S Howe, D Zöphel, H Subbaraman, C Unger, J Held, T Engleitner, ... Antimicrobial agents and chemotherapy 59 (2), 1193-1199, 2015 | 34 | 2015 |
| A PfSPZ vaccine immunization regimen equally protective against homologous and heterologous controlled human malaria infection B Mordmüller, Z Sulyok, M Sulyok, Z Molnar, A Lalremruata, CL Calle, ... npj Vaccines 7 (1), 100, 2022 | 32 | 2022 |
| Mitochondrial localization of the threonine peptidase PfHslV, a ClpQ ortholog in Plasmodium falciparum S Tschan, A Kreidenweiss, YD Stierhof, N Sessler, R Fendel, ... International journal for parasitology 40 (13), 1517-1523, 2010 | 28 | 2010 |
| Molecular Evidence of Wolbachia Endosymbiosis in Mansonella perstans in Gabon, Central Africa C Gehringer, A Kreidenweiss, A Flamen, JS Antony, MP Grobusch, ... The Journal of infectious diseases 210 (10), 1633-1638, 2014 | 27 | 2014 |
| SARS-CoV-2 antibodies are persisting in saliva for more than 15 months after infection and become strongly boosted after vaccination YT Pinilla, C Heinzel, LF Caminada, D Consolaro, M Esen, PG Kremsner, ... Frontiers in Immunology 12, 798859, 2021 | 26 | 2021 |
| Drug repurposing: a review of old and new antibiotics for the treatment of malaria: identifying antibiotics with a fast onset of antiplasmodial action L Pessanha de Carvalho, A Kreidenweiss, J Held Molecules 26 (8), 2304, 2021 | 26 | 2021 |
